|
|
Science Sparks @ ACTREC
|
24th February 2025 |
Vol. No. 14 ; Issue No.671 |
|
Publications
|
1. Chaudhary N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Baar J, Dani J, Sahoo S, Soundharya R, Jolly MK, Verma N (2025). EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. Cancer Cell International. 25(1): 55
2. Noronha V, Choudhary J, Ramaswamy A, Pillai A, Rao AR, Kumar A, Dhekale R, Mahajan S, Daptardar A, Sonkusare L, Vagal M, Mahajan P, Timmanpyati S, Gota V, Shetake AG, Pawar A, Prabhash K (2025). Treatment goals, desire for disclosure, and perception of cancer treatment outcomes in older patients with cancer: An observational study from a tertiary care center in India. Journal of Geriatric Oncology. 16(3):102198.
3. Menon SR, Sahu S, Mitra A, Chakraborty A, Malhotra G, Kamaldeep, Tawate M, Lad S, Rakshit S, Upadhye T, Ray MK, Banerjee S (2025). On the automated radiosynthesis of pharmaceutical grade [68Ga]Ga-Pentixafor, its pre-clinical evaluation, clinical application and radiation dosimetry aspects. Scientific Reports. 15(1):6476.
|
|
|
Interesting Reads
|
Thiel V, Renders S, Panten J, Dross N, Bauer K, Azorin D, Henriques V, Vogel V, Klein C, Leppä AM, Barriuso Ortega I, Schwickert J, Ourailidis I, Mochayedi J, Mallm JP, Müller-Tidow C, Monyer H, Neoptolemos J, Hackert T, Stegle O, Odom DT, Offringa R, Stenzinger A, Winkler F, Sprick M, Trumpp A (2025). Characterization of single neurons reprogrammed by pancreatic cancer. Nature.
|
|
Video of the Week
|
|
Chasing the Cure: Drug Tolerance and Targeted Therapy in Breast Cancer |
|
|
|
|
|
|
Do You Know?
In 1977, Memorial Sloan Kettering became the world’s first cancer center to establish a full-time psychiatry service devoted solely to treating psychiaric and psychological problems unique to cancer patients.
|
|
|
Cancer News
|
|
Scientists identify epigenetic key that 'opens' door to colon cancer.
|
MedicalXpress, 20/02/2025
|
The gene codes for the HMGA1 protein, a so-called 'epigenetic regulator,' which means that it modulates the structure of our genome, opening or closing different zones to activate or repress genes. Epigenetic regulators alter gene expression in response to many different factors...
|
|
|
|
|
|
|
FDA approves injectable Nivolumab, an alternative to IV infusion.
|
National Cancer Institute, 19/02/2025
|
A form of nivolumab that can be injected under the skin (subcutaneous) has gained approval from the Food and Drug Administration (FDA). The approval allows the injectable version to be used for most of the same patient groups as the original formulation...
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|